Anti-ErbB2 scFv h(CD28) CARNK, pCDCAR1
- 1.00 Dollar US$
- Published date: March 6, 2018
-
- Shirley, New York, United States
https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-28-nk-277.htm The vector of anti-ErbB2 (HER2) chimeric antigen receptor(CAR) is constructed for the engineering of NK cell to target human ErbB2. The NK cell is genetically modified through transduction with a lentiviral vector expressing scFv of anti-ErbB2 antibody linked to CD28 signaling domains. And the vector product was designed for the treatment of breast carcinomas, ovarian carcinoma .










Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
Anti-ErbB2 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-28oxζ-t-276.htm The vector of anti-ErbB2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human ErbB2. The T cells are genetically modified through transduc...
-
Anti-ErbB2 scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-28bbζ-t-275.htm The vector of anti-ErbB2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human ErbB2. The T cells are genetically modified through transduc...
-
Anti-ErbB2 scFv h(b2c-CD3ζ) CART, pCDCAR1
Drug Development Shirley (New York) March 6, 2018 1.00 Dollar US$https://www.creative-biolabs.com/car-t/pcdcar1-erbb2-h-b2cζ-t-274.htm The vector of anti-ErbB2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human ErbB2. The T cells are genetically modified through transduct...